This site is intended for health professionals only
Sunday 19 May 2019
Share |

Global pharmaceutical organisations partner up to improve access for ALS treatment

Global pharmaceutical organisations have joined forces to improve access to a treatment for amyotrophic lateral sclerosis (ALS).


Clinigen Group plc has partnered with Mitsubishi Tanabe Pharma Corporation (MTPC) in Europe to initiate a ‘Managed Access Program’ for Edaravone, an intravenous treatment for ALS. The initiative is also known as ‘Early Access Program’.


Edaravone has been approved for use as a treatment for ALS in Japan, South Korea and the USA.


ALS is an idiopathic neurodegenerative disease in which motor neurons selectively degenerate and vanish. Muscle strength declines throughout the entire body, including the limb, facial, and respiratory muscles, and muscular atrophy progress.


There is a lack of understanding about causes for the majority of ALS cases, but it may involve genetic and environmental factors. This neuromuscular disease affects approximately two in 100,000 people worldwide.


Commenting on the partnership, John Lagus, head of managed access, Clinigen, said the organisation was “pleased to work again with MTPC to help eligible patients in Europe gain access to this important medicine”.


As the trusted global leader in access to unlicensed medicines, this partnership aligns with our mission of getting the right medicines to the right patient at the right time,” he said.


Access to more information can also be obtained through Cliniport at

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher